NCT02660931|Completed
Pediatric Acute Kidney Injury (AKI) Retrospective, Real-Time and Repository Research
PAR4
Loading search results
PAR4
Sponsor study identifier
interventional
12,108
1 country
1
Study Start
November 2016
Actual (reported)Primary Completion
November 2017
Actual (reported)Study Completion
November 2018
Actual (reported)This proposal will incorporate statistical models developed by the investigators to predict risk for acute kidney injury into our electronic medical record system, enabling an alert to notify providers of the risk status. Pediatric inpatients will be randomly assigned to be in the intervention group, for whom the notification will be implemented, or in the control group, who will receive usual care (no notification). The investigators believe the notification will increase appropriate screening for acute kidney injury and reduce the severity of acute kidney injury in the intervention group.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 18, 2016
Actual (reported)January 21, 2016
Actual (reported)November 2016
Actual (reported)November 2017
Actual (reported)November 2018
Actual (reported)Number of Serum Creatinine Tests Ordered
Measure of efficacy of the clinical decision support to lead to increased screening for acute kidney injury.
Admission through Discharge (approximately 2 days to 1 week)
Length of Stay (days)
Admission through Discharge (approximately 2 days to 1 week)
Acute Kidney Injury Severity (as measured by Kidney Disease Improving Global Outcomes [KDIGO] stage 1, 2 or 3)
Admission through Discharge (approximately 2 days to 1 week)
In-hospital Mortality
Admission through Discharge (approximately 2 days to 1 week)
Renal Replacement Therapy (number requiring RRT)
Admission through Discharge (approximately 2 days to 1 week)
Patients randomized to this arm will be eligible for an acute kidney injury risk notification, if their calculated risk exceeds the threshold during their inpatient encounter.
These patients will receive usual clinical care, with no acute kidney injury risk notification.
When a patient's calculated acute kidney injury risk exceeds the threshold value, the electronic medical record will notify the provider of the risk and that appropriate screening (BMP including serum creatinine) may be indicated.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Monroe Carell Jr. Children's Hospital at Vanderbilt
Nashville, Tennessee, 37232, United States
Sara L Van Driest, MD, PhD
Vanderbilt University Medical Center
12,108 participants (actual enrollment reported by the registry).
First Submitted
January 18, 2016
First Posted
January 21, 2016
Study Start
November 2016
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
November 2017
Actual (reported)Study Completion
November 2018
Actual (reported)Last Updated
April 3, 2019
Record last verified: 2019-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: